FRONTIERS IN BIOSCIENCE;

DATA FORM FOR CANCER STAGING - URINARY BLADDER




FORM # 785-1-046

CLIN PATH DEFINITIONS
    PRIMARY TUMOR (T)

TX Primary tumor cannot be assessed

T0 No evidence of primary tumor

Ta Non invasive papillary carcinoma

Tis Carcinoma in situ: "flat tumor"

T1 Tumor invades subepithelial connective tissue

T2 Tumor invades superficial muscle (inner half)

T3 Tumor invades deep muscle or perivesical fat
      T3a Tumor invades deep muscle (outer half)
      T3b Tumor invades perivesical fat
      i. microscopically
      ii. macroscopically (extravesical mass)

T4 Tumor invades prostate, uterus, vagina, pelvic wall or abdominal wall
      T4a Tumor invades prostate, uterus, vagina
      T4b Tumor invades pelvic wall or abdominal wall
    LYMPH NODE (N)

NX Regional lymph nodes cannot be assessed

N0 No regional lymph node metastasis

N1 Metastasis in a single lymph node, 2 cm or less in greatest dimension

N2 Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension, or multiple lymph nodes, none more than 5 cm in greatest dimension

N3 Metastasis in a lymph node more than 5 cm in greatest dimension
    DISTANT METASTASIS (M)

MX Presence of distant metastasis cannot be assessed

M0 No distant metastasis

M1 Distant metastasis

Pathologic Stage by: M.D. Date:

CLIN PATH STAGE GROUPING

0a Ta N0 M0

0is Tis N0 M0

I T1 N0 M0

II T2 N0 M0
      T3a N0 M0

III T3b N0 M0
      T4a N0 M0

IV T4b N0 M0
      Any T N1 M0
      Any T N2 M0
      Any T N3 M0
      Any T Any N M1

Attending: M.D. Date:

THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.

Comments:
Patient Name: